Cas9 nickase–mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington’s disease mouse model
Science Translational Medicine · 21.10.2026 · 18 (872)
DOI: 10.1126/scitranslmed.aef9466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 21.10.2026. Verfasst von Alvaro Murillo und 24 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute at Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK. Hauptthemen laut MEDLINE: Huntington Disease, Trinucleotide Repeat Expansion, Deoxyribonuclease I, CRISPR-Cas Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Myotonic Dystrophy Foundation, CHDI Foundation, Huntington Society of Canada.
Abstract (Originalsprache)
Expanded CAG/CTG repeats cause more than 15 different diseases that all remain without a disease-modifying treatment. Because repeat length accounts for most of the variation in disease severity, contracting CAG/CTG repeats presents an attractive therapeutic avenue. Here, we show that the CRISPR-Cas9 nickase targeted to CAG/CTG repeats leads to efficient repeat contractions in Huntington’s disease (HD) patient–derived neurons and astrocytes and in myotonic dystrophy type 1 patient–derived neurons. The approach was allele selective and free of detectable off-target mutations. Injection of the Cas9 nickase into the striatum of the R6/1 mouse model of HD using adeno-associated viral vectors led to repeat contractions in more than half of striatal neurons. Upon injection, we observed a reduction in the number of inclusion bodies, an improved gene expression profile, and amelioration of locomotion deficits in the open field test. The effects were greater than expected from the contractions induced, suggesting that non–cell autonomous mechanisms may be involved. Our results provide the proof of concept that correction of CAG/CTG repeats can improve HD phenotypes in a mouse disease model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UK Dementia Research Institute at Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.
- Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
- Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff CF10 3AX, UK.
- Department of Neurodegenerative Disease, Huntington's Disease Centre, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
- UK Dementia Research Institute, University of Cambridge, Clifford Albutt Building, Cambridge Biomedical Campus, Cambridge CB2 0AH, UK.
ORCID-Profile: Alvaro Murillo, Melanie Alpaugh, Ruban Rex Peter Durairaj, Emma L Randall, Meghan Larin, Laura Heraty, Alys N Aston, Alysha S Taylor, Alex Mas Monteys, Nina Stöberl, Aeverie E R Heuchan, Pascale Aeschlimann, Kyle Fears, Christian Landles, Georgina F Osborne, Antoine Mangin, Soumyasree Bhattacharyya, Emmanouil Metzakopian, Nicholas D Allen, Jack Puymirat, Gillian P Bates, Beverly L Davidson, Francesca Cicchetti, Mariah J Lelos, Vincent Dion
Förderung
- Myotonic Dystrophy Foundation
- CHDI Foundation
- Huntington Society of Canada
- Medical Research Council
- Academy of Medical Sciences
- European Research Council
- UK Dementia Research Institute
- The Sigrid Rausing Trust
Zitieren
APA
Murillo, A., Alpaugh, M., Peter Durairaj, R. R., Randall, E. L., Larin, M., Heraty, L., Aston, A. N., Taylor, A. S., Monteys, A. M., Stöberl, N., Heuchan, A. E. R., Aeschlimann, P., Fears, K., Landles, C., Osborne, G. F., Mangin, A., Bhattacharyya, S., Metzakopian, E., Allen, N. D., …, & Dion, V. (2026). Cas9 nickase–mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington’s disease mouse model. Science Translational Medicine, 18(872). https://doi.org/10.1126/scitranslmed.aef9466
Vancouver
Murillo A, Alpaugh M, Peter Durairaj RR, Randall EL, Larin M, Heraty L, et al. Cas9 nickase–mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington’s disease mouse model. Science Translational Medicine. 2026;18(872). doi:10.1126/scitranslmed.aef9466
BibTeX
@article{Murillo2026,
author = {Murillo, Alvaro and Alpaugh, Melanie and Peter Durairaj, Ruban Rex and Randall, Emma L and Larin, Meghan and Heraty, Laura and Aston, Alys N and Taylor, Alysha S and Monteys, Alex Mas and Stöberl, Nina and Heuchan, Aeverie E R and Aeschlimann, Pascale and Fears, Kyle and Landles, Christian and Osborne, Georgina F and Mangin, Antoine and Bhattacharyya, Soumyasree and Metzakopian, Emmanouil and Allen, Nicholas D and Puymirat, Jack and Bates, Gillian P and Davidson, Beverly L and Cicchetti, Francesca and Lelos, Mariah J and Dion, Vincent},
title = {Cas9 nickase–mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington’s disease mouse model},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {872},
doi = {10.1126/scitranslmed.aef9466}
}
EUVIMED